Advanced search
Publication Cover
Ophthalmic Epidemiology Volume 11, 2004 - Issue 5
Submit an article Journal homepage
74
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Model study of AREDS antioxidant supplementation of AMD compared to Visudyne: A dominant strategy?

John Trevithick Department of Biochemistry Faculty of Medicine, University of Western Ontario London CanadaCorrespondence[email protected]
,
David Massel Department of Medicine Faculty of Medicine, University of Western Ontario London Canada
,
James Robertson Departments of Epidemiology & Biostatistics Faculty of Medicine, University of Western Ontario London Canada
,
Sandy Tomany Center for the Advancement of Urban Children Medical College of Wisconsin Milwaukee Wisconsin USA
&
Ronald Wall Departments of Epidemiology & Biostatistics Faculty of Medicine, University of Western Ontario London Canada; Canadian Institute for Health Information Ottawa Ontario Canada
Pages 337-346 | Published online: 08 Jul 2009

References

  • Verteporfin Roundtable 2000 and 2001 Participants. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina. 2002;22: 6–18.
  • Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch OphthalmoL 2001;119: 1417–1436.
  • Statistics Canada. Population Projections for Canada, Provinces and Territories, 2000–2026. Ottawa, Ontario: Statistics Canada, 2000.
  • U.S. Bureau of the Census. Statistical Abstract of the United States 1993. Washington, D.C.: U.S. Bureau of the Census, 1993;113 (Projection 2).
  • Liebowitz HM, Kreuger DE, Maunder LR, et al. The Framingham Study Monograph. Surv OphthalmoL 1989;24(Suppl): 335-61o.
  • Kahn HA, Leibowitz HM, et al. The Framingham Eye Study I. Outline and major prevalence findings. Am J EpidemioL 1977;1o6: 17–32.
  • Young RW. Pathophysiology of age-related macular degeneration. &ITV OphthalmoL 1987;31: 291–306.
  • Young RW. Solar radiation and age-related macular degeneration. Surv OphthalmoL 1988;32:252–269.
  • Young RW. The family of sunlight-related diseases. Optom Vis ScL 1994;71:125–144.
  • Podgor MJ, Leske MC, Ederer E Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy. Am J Epidemiol. 1083;118:206–212.
  • Klein R, Tomany S. Prevalence and progression of age-related macular degeneration in the Beaver Dam Eye Study. Personal Communication (17-7–2002).
  • Drummond MF, Davies LM, Ferris FL III. Assessing the costs and benefits of medical research: the diabetic retinopathy study. Soc Sci Med. 1992;34:973–981.
  • Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:7–21.
  • West S, Vitale S, Hallfrisch J, et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol. 1994;112:222–227.
  • Lipscomb J. Time Preference. In: Gold MR (Ed.). Cost Effectiveness in Health and Medicine. Oxford: Oxford University Press, 1006;214–246.
  • Niki E, Noguchi N, Tsuchihashi H, Gotoh N. Interaction among vitamin C, vitamin E, and beta-carotene. Am J Clin Nutr. 1995;62:13225–13265.
  • Laupacis A, Feeny D, Detsky AS, Tugwell PX. Tentative guidelines for using clinical and economic evaluations revisited. Can Med Assoc J. 1003;148:027–020.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.